#1 Clinical Trials Search in Europe

Dexamethasone Acetate

This article examines the use of Dexamethasone Acetate in various clinical trials. Dexamethasone Acetate is a corticosteroid medication being studied for its potential benefits in treating different medical conditions, from pain management to respiratory issues. The trials aim to evaluate its effectiveness, optimal dosing, and safety profile across multiple therapeutic areas.

Table of Contents

What is Dexamethasone Acetate?

Dexamethasone acetate is a type of medication known as a corticosteroid or steroid. It’s a synthetic version of hormones naturally produced by your adrenal glands[1]. This drug is known for its potent anti-inflammatory and immunosuppressive properties, making it useful in treating various medical conditions[2].

Medical Uses

Dexamethasone acetate is used to treat a wide range of conditions, including:

  • Postoperative Nausea and Vomiting (PONV): It’s used to prevent and treat nausea and vomiting after surgery, particularly in patients undergoing eye surgeries like vitrectomy[3].
  • COVID-19: Dexamethasone has shown effectiveness in treating severe COVID-19 cases, particularly in patients requiring oxygen therapy[4].
  • Brain Tumors: It’s used to reduce swelling and manage symptoms in children undergoing radiation therapy for brain tumors[5].
  • Multiple Myeloma: Dexamethasone is often part of combination therapies for treating this type of blood cancer[6].
  • Tuberculous Meningitis: It’s being studied for its potential benefits in treating this severe form of tuberculosis that affects the brain[7].
  • Pain Management: It’s used in combination with local anesthetics for pain control after certain surgical procedures[8].

How is Dexamethasone Administered?

Dexamethasone acetate can be administered in several ways, depending on the condition being treated:

  • Oral: Taken by mouth as tablets or liquid[5].
  • Intravenous (IV): Injected directly into a vein[3].
  • Local injection: Injected near specific nerves for pain management[8].

The dosage and duration of treatment can vary significantly depending on the condition being treated and the individual patient’s needs[5].

Effectiveness

Research has shown dexamethasone acetate to be effective in various medical scenarios:

  • In preventing postoperative nausea and vomiting, especially when combined with other anti-nausea medications[3].
  • For reducing mortality in severe COVID-19 cases requiring oxygen therapy[4].
  • In managing symptoms related to brain tumors and their treatment in children[5].
  • As part of combination therapies for multiple myeloma[6].

Side Effects and Precautions

While dexamethasone acetate can be very effective, it may also cause side effects. These can include:

  • Increased risk of infections
  • Changes in blood sugar levels
  • Mood changes or psychiatric effects
  • Changes in appetite and weight
  • Fluid retention

Long-term use of dexamethasone may lead to more serious side effects. It’s important to take this medication exactly as prescribed by your doctor and to discuss any concerns or side effects you experience[5].

Ongoing Research

Researchers continue to study dexamethasone acetate to better understand its effects and potential uses. Current areas of research include:

  • Optimal dosing for various conditions, including comparing low-dose versus high-dose regimens[5].
  • Its effectiveness in combination with other medications for treating multiple myeloma[6].
  • Its potential role in treating tuberculous meningitis, including how genetic factors might influence its effectiveness[7].
  • Its use in pain management techniques, such as nerve blocks[8].
Aspect Details
Medical Conditions Studied Post-surgical pain, tuberculous meningitis, bone metastases pain, glioblastoma, post-extubation complications, keratoconus
Administration Methods Intravenous, oral, topical cream, intracanalicular insert
Comparison Groups Placebo, other medications (e.g., clotrimazole, prednisolone), different dosing schedules
Primary Outcomes Measured Pain relief, duration of analgesia, neurocognitive function, inflammation reduction, stridor prevention
Safety Monitoring Adverse events, effects on blood sugar, immune function, muscle strength
Trial Durations Ranging from days to several months, with some including long-term follow-up

FAQ

  • What is Dexamethasone Acetate? Dexamethasone Acetate is a type of corticosteroid medication that has anti-inflammatory and immunosuppressive properties. It's being studied in clinical trials for various medical conditions.
  • What conditions are being studied with Dexamethasone Acetate? Clinical trials are exploring its use in pain management after surgery, treatment of tuberculous meningitis, prevention of pain flares after radiation therapy for bone metastases, management of glioblastoma, and prevention of post-extubation complications in intensive care patients.
  • How is Dexamethasone Acetate administered in these trials? The administration method varies depending on the study. It may be given intravenously, orally, or as part of a cream for topical application. Some trials are comparing different dosing schedules or administration routes.
  • Are there any side effects associated with Dexamethasone Acetate? While specific side effects aren't detailed in the trial summaries, corticosteroids like Dexamethasone Acetate can have side effects. The trials are monitoring for potential adverse events, including effects on blood sugar levels and immune function.
  • How long do these clinical trials typically last? The duration of the trials varies widely, from a few days for acute conditions to several weeks or months for longer-term studies. Some trials involve follow-up assessments weeks or months after the initial treatment period.

Ongoing Clinical Trials on Dexamethasone Acetate

  • Study of sacituzumab tirumotecan, pembrolizumab and chemotherapy combination for early-stage triple-negative breast cancer or hormone receptor-low positive/HER2-negative breast cancer

    Recruiting

    1 1 1 1
    Investigated drugs:
    Belgium Czechia Finland France Germany Greece +8

  • Study of Opevesostat, Olaparib, and Cabazitaxel in Patients with Advanced Prostate Cancer

    Recruiting

    1 1 1
    Investigated drugs:
    Denmark Finland France Germany Ireland Italy +2

  • Study of Pembrolizumab and MK-2870 for Patients with Metastatic Squamous Non-small Cell Lung Cancer

    Recruiting

    1 1 1 1
    Investigated drugs:
    Austria Czechia France Germany Hungary Ireland +4

  • Study Comparing MK-5684 with Abiraterone Acetate or Enzalutamide for Patients with Advanced Prostate Cancer After Hormonal Therapy and Chemotherapy

    Recruiting

    1 1 1 1
    Investigated drugs:
    Austria Czechia Denmark Finland France Germany +8

  • Study on the Safety and Dosage of GD2IL18CART for Patients with Relapsed or Refractory GD2 Positive Solid Cancers

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany

  • Study Comparing MK-5684 with Abiraterone Acetate or Enzalutamide for Patients with Advanced Prostate Cancer After Hormonal Therapy

    Recruiting

    1 1 1 1
    Investigated drugs:
    Czechia Estonia France Germany Greece Hungary +9

  • Study of Pembrolizumab, Vibostolimab, and Belzutifan for Patients with Metastatic Castration-Resistant Prostate Cancer

    Recruiting

    1 1 1
    Investigated drugs:
    Austria Denmark Finland France Germany Ireland +5

  • Study on Lymphoblastic Lymphoma Treatment in Children and Adolescents Using Dexamethasone, Prednisone, and PEG-Asparaginase

    Recruiting

    1 1 1 1
    Investigated drugs:
    Austria Belgium Czechia Denmark Finland Germany +8

  • Study on the Safety and Effectiveness of BGB-11417 Alone and with Dexamethasone, Carfilzomib, Daratumumab, or Pomalidomide for Patients with Relapsed or Refractory Multiple Myeloma

    Recruiting

    1 1 1
    Investigated drugs:
    France Germany Greece Italy Spain

  • Study Comparing MK-2870 and Pembrolizumab with Chemotherapy for Patients with Advanced Hormone Receptor Positive Breast Cancer

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Czechia Denmark France Germany Greece +10

Glossary

  • Corticosteroid: A class of steroid hormones produced in the adrenal cortex or made synthetically. They have various metabolic functions and are used to treat inflammation.
  • Tuberculous Meningitis: An infection of the membranes covering the brain and spinal cord (meninges) caused by tuberculosis bacteria.
  • Glioblastoma Multiforme: An aggressive type of cancer that occurs in the brain or spinal cord.
  • Transverse Abdominis Plane (TAP) Block: A regional anesthesia technique that provides pain relief to the abdominal wall.
  • Pain Flare: A temporary increase in pain that can occur after radiation therapy for bone metastases.
  • Bone Metastases: Cancer that has spread from its original site to the bone.
  • Neurocognitive Function: Brain-based skills and mental processes needed to carry out any task, including memory, attention, and problem-solving abilities.
  • Placebo: An inactive substance or treatment used in clinical trials as a control to compare against the active medication being studied.
  • Randomized Controlled Trial: A type of scientific experiment where participants are randomly assigned to different treatment groups to compare outcomes.
  • Intracanalicular: Referring to placement within a small canal, in this context, within tear ducts.

References

  1. https://clinicaltrials.gov/study/NCT00516009
  2. https://clinicaltrials.gov/study/NCT00817479
  3. https://clinicaltrials.gov/study/NCT02386059
  4. https://clinicaltrials.gov/study/NCT04765371
  5. https://clinicaltrials.gov/study/NCT01135550
  6. https://clinicaltrials.gov/study/NCT02586038
  7. https://clinicaltrials.gov/study/NCT02588196
  8. https://clinicaltrials.gov/study/NCT02838719